Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FNMMX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,886.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award, issued on October 17, 2025, with an ultimate completion date of November 7, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense's pharmaceutical supply chain, demonstrating substantial contracting activity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The company's extensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The underlying PPV-G GEN V contract, awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors and authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FNMMX?
SPE2DB26FNMMX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FNMMX worth?
The government has obligated $13,886 on SPE2DB26FNMMX.
Is contract SPE2DB26FNMMX an order under another contract?
Yes. SPE2DB26FNMMX is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMMX competed?
The extent of competition for SPE2DB26FNMMX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award